Tasigna Capsules 150mg by Novartis Pharma features Nilotinib hydrochloride hydrate, indicated for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). This 150mg 1 capsule formulation is identified by YJ code 4291021M2027.
Tasigna Capsules 150mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
